Showing results (1-10 of 4,403) with videos related to

Sort By:
Pageof 441
Critical Reviews in Oncology/Hematology|January 1, 1985
Iron deficiency and iron overloadA Jacobs
Critical Reviews in Oncology/Hematology|December 8, 2022
Exosomes in sarcoma: Prospects for clinical applicationsHuali Ye, Linyun Tan, Chongqi Tu, et al.
Critical Reviews in Oncology/Hematology|December 8, 2022
The prognostic impact of tumor-infiltrating B lymphocytes in patients with solid malignancies: A systematic review and meta-analysisHao Liu, Zhuoqun Li, Xuan Han, et al.
Critical Reviews in Oncology/Hematology|January 1, 1987
Inhibitors of coagulation in childrenF Desposito, Y Arkel
Critical Reviews in Oncology/Hematology|August 28, 2020
Management of metabolic adverse events of targeted therapies and immune checkpoint inhibitors in cancer patients: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paperNicola Silvestris, Antonella Argentiero, Giordano Domenico Beretta, et al.
Critical Reviews in Oncology/Hematology|September 14, 2020
Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistanceSara M Elgendy, Shatha K Alyammahi, Dima W Alhamad, et al.
Critical Reviews in Oncology/Hematology|May 27, 2021
The diverse molecular profiles of lynch syndrome-associated colorectal cancers are (highly) dependent on underlying germline mismatch repair mutationsNoah C Helderman, Sanne W Bajwa-Ten Broeke, Hans Morreau, et al.
Critical Reviews in Oncology/Hematology|July 10, 2021
Cetuximab in locally advanced head and neck squamous cell carcinoma: Biological mechanisms involved in efficacy, toxicity and resistanceElena Muraro, Giuseppe Fanetti, Valentina Lupato, et al.
Critical Reviews in Oncology/Hematology|November 30, 2020
The main sources of circulating cell-free DNA: Apoptosis, necrosis and active secretionZijian Hu, Honghong Chen, Yanzhu Long, et al.
Critical Reviews in Oncology/Hematology|December 5, 2020
Neoadjuvant immune checkpoint inhibitors in cancer, current state of the artOlivia Le Saux, Yasmine Lounici, Pauline Wajda, et al.
Pageof 441